GEN ranks not only the top 10 publicly traded developed of editing-based therapies, but the top five privately held companies ...

A Roots Analysis study showed the market for ADC manufacturing is $1.79 billion today, but is expected to grow to $7 billion ...

Nanoneedle tech could enable disease monitoring in real time, allowing clinicians to take multiple, repeatable tests from the ...

Chrysalis partners with life science clients, from early-stage biofirms to pharmaceutical firms, CROs, and other life science ...

PepGen leverages a graph-based approach to improve the detection of hidden protein variants in a computationally efficient manner.